TY - JOUR AU - Stark, A. K. AU - Sriskantharajah, S. AU - Hessel, E. M. AU - Okkenhaug, K. PY - 2015 DA - 2015// TI - PI3K inhibitors in inflammation, autoimmunity and cancer JO - Curr Opin Pharmacol VL - 23 UR - https://doi.org/10.1016/j.coph.2015.05.017 DO - 10.1016/j.coph.2015.05.017 ID - Stark2015 ER - TY - JOUR AU - Okkenhaug, K. AU - Graupera, M. AU - Vanhaesebroeck, B. PY - 2016 DA - 2016// TI - Targeting PI3K in Cancer: impact on tumor cells, their protective stroma, angiogenesis, and immunotherapy JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0716 DO - 10.1158/2159-8290.CD-16-0716 ID - Okkenhaug2016 ER - TY - JOUR AU - Soond, D. R. AU - Bjorgo, E. AU - Moltu, K. AU - Dale, V. Q. AU - Patton, D. T. AU - Torgersen, K. M. PY - 2010 DA - 2010// TI - PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-232330 DO - 10.1182/blood-2009-07-232330 ID - Soond2010 ER - TY - JOUR AU - Garcon, F. AU - Patton, D. T. AU - Emery, J. L. AU - Hirsch, E. AU - Rottapel, R. AU - Sasaki, T. PY - 2008 DA - 2008// TI - CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-08-108050 DO - 10.1182/blood-2007-08-108050 ID - Garcon2008 ER - TY - JOUR AU - Kim, E. H. AU - Suresh, M. PY - 2013 DA - 2013// TI - Role of PI3K/Akt signaling in memory CD8 T cell differentiation JO - Front Immunol VL - 4 ID - Kim2013 ER - TY - JOUR AU - Fruman, D. A. AU - Rommel, C. PY - 2011 DA - 2011// TI - PI3Kdelta inhibitors in cancer: rationale and serendipity merge in the clinic JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0249 DO - 10.1158/2159-8290.CD-11-0249 ID - Fruman2011 ER - TY - JOUR AU - Kaneda, M. M. AU - Messer, K. S. AU - Ralainirina, N. AU - Li, H. AU - Leem, C. J. AU - Gorjestani, S. PY - 2016 DA - 2016// TI - PI3Kgamma is a molecular switch that controls immune suppression JO - Nature VL - 539 UR - https://doi.org/10.1038/nature19834 DO - 10.1038/nature19834 ID - Kaneda2016 ER - TY - JOUR AU - Crompton, J. G. AU - Sukumar, M. AU - Roychoudhuri, R. AU - Clever, D. AU - Gros, A. AU - Eil, R. L. PY - 2015 DA - 2015// TI - Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2277 DO - 10.1158/0008-5472.CAN-14-2277 ID - Crompton2015 ER - TY - JOUR AU - Waart, A. B. AU - Weem, N. M. AU - Maas, F. AU - Kramer, C. S. AU - Kester, M. G. AU - Falkenburg, J. H. PY - 2014 DA - 2014// TI - Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-05-578583 DO - 10.1182/blood-2014-05-578583 ID - Waart2014 ER - TY - JOUR AU - Abu Eid, R. AU - Friedman, K. M. AU - Mkrtichyan, M. AU - Walens, A. AU - King, W. AU - Janik, J. PY - 2015 DA - 2015// TI - Akt1 and −2 inhibition diminishes terminal differentiation and enhances central memory CD8+ T-cell proliferation and survival JO - Oncoimmunology VL - 4 UR - https://doi.org/10.1080/2162402X.2015.1005448 DO - 10.1080/2162402X.2015.1005448 ID - Abu Eid2015 ER - TY - JOUR AU - Ali, K. AU - Soond, D. R. AU - Pineiro, R. AU - Hagemann, T. AU - Pearce, W. AU - Lim, E. L. PY - 2014 DA - 2014// TI - Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer JO - Nature VL - 510 UR - https://doi.org/10.1038/nature13444 DO - 10.1038/nature13444 ID - Ali2014 ER - TY - JOUR AU - Abu Eid, R. AU - Ahmad, S. AU - Lin, Y. AU - Webb, M. AU - Berrong, Z. AU - Shrimali, R. PY - 2017 DA - 2017// TI - Enhanced therapeutic efficacy and memory of tumor-specific CD8 T cells by ex vivo PI3K-delta inhibition JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1925 DO - 10.1158/0008-5472.CAN-16-1925 ID - Abu Eid2017 ER - TY - JOUR AU - Ahmad, S. AU - Abu-Eid, R. AU - Shrimali, R. AU - Webb, M. AU - Verma, V. AU - Doroodchi, A. PY - 2017 DA - 2017// TI - Differential PI3Kdelta signaling in CD4+ T-cell subsets enables selective targeting of T regulatory cells to enhance Cancer immunotherapy JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1839 DO - 10.1158/0008-5472.CAN-16-1839 ID - Ahmad2017 ER - TY - JOUR AU - Hudson, K. AU - Hancox, U. J. AU - Trigwell, C. AU - McEwen, R. AU - Polanska, U. M. AU - Nikolaou, M. PY - 2016 DA - 2016// TI - Intermittent high-dose scheduling of AZD8835, a novel selective inhibitor of PI3Kalpha and PI3Kdelta, demonstrates treatment strategies for PIK3CA-dependent breast cancers JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0687 DO - 10.1158/1535-7163.MCT-15-0687 ID - Hudson2016 ER - TY - JOUR AU - Bowers, J. S. AU - Majchrzak, K. AU - Nelson, M. H. AU - Aksoy, B. A. AU - Wyatt, M. M. AU - Smith, A. S. PY - 2017 DA - 2017// TI - PI3Kdelta inhibition enhances the antitumor fitness of adoptively transferred CD8(+) T cells JO - Front Immunol VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01221 DO - 10.3389/fimmu.2017.01221 ID - Bowers2017 ER - TY - STD TI - Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours. https://ClinicalTrials.gov/show/NCT02260661. UR - https://clinicaltrials.gov/show/NCT02260661 ID - ref16 ER - TY - JOUR AU - Mosely, S. I. AU - Prime, J. E. AU - Sainson, R. C. AU - Koopmann, J. O. AU - Wang, D. Y. AU - Greenawalt, D. M. PY - 2017 DA - 2017// TI - Rational selection of syngeneic preclinical tumor models for immunotherapeutic drug discovery JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0114 DO - 10.1158/2326-6066.CIR-16-0114 ID - Mosely2017 ER - TY - JOUR AU - Wei, S. C. AU - Levine, J. H. AU - Cogdill, A. P. AU - Zhao, Y. AU - Anang, N. A. S. AU - Andrews, M. C. PY - 2017 DA - 2017// TI - Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade JO - Cell VL - 170 UR - https://doi.org/10.1016/j.cell.2017.07.024 DO - 10.1016/j.cell.2017.07.024 ID - Wei2017 ER - TY - JOUR AU - Kim, K. AU - Skora, A. D. AU - Li, Z. AU - Liu, Q. AU - Tam, A. J. AU - Blosser, R. L. PY - 2014 DA - 2014// TI - Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1410626111 DO - 10.1073/pnas.1410626111 ID - Kim2014 ER - TY - JOUR AU - Abu-Eid, R. AU - Samara, R. N. AU - Ozbun, L. AU - Abdalla, M. Y. AU - Berzofsky, J. A. AU - Friedman, K. M. PY - 2014 DA - 2014// TI - Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway JO - Cancer Immunol Res VL - 2 UR - https://doi.org/10.1158/2326-6066.CIR-14-0095 DO - 10.1158/2326-6066.CIR-14-0095 ID - Abu-Eid2014 ER - TY - JOUR AU - Sai, J. AU - Owens, P. AU - Novitskiy, S. V. AU - Hawkins, O. E. AU - Vilgelm, A. E. AU - Yang, J. PY - 2017 DA - 2017// TI - PI3K inhibition reduces mammary tumor growth and facilitates antitumor immunity and anti-PD1 responses JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-2142 DO - 10.1158/1078-0432.CCR-16-2142 ID - Sai2017 ER - TY - JOUR AU - Blankley, S. AU - Berry, M. P. AU - Graham, C. M. AU - Bloom, C. I. AU - Lipman, M. AU - O'Garra, A. PY - 2014 DA - 2014// TI - The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis JO - Philos Trans R Soc Lond Ser B Biol Sci VL - 369 UR - https://doi.org/10.1098/rstb.2013.0427 DO - 10.1098/rstb.2013.0427 ID - Blankley2014 ER - TY - JOUR AU - Lynch, J. T. AU - Polanska, U. M. AU - Delpuech, O. AU - Hancox, U. AU - Trinidad, A. G. AU - Michopoulos, F. PY - 2017 DA - 2017// TI - Inhibiting PI3Kbeta with AZD8186 regulates key metabolic pathways in PTEN-null tumors JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-17-0676 DO - 10.1158/1078-0432.CCR-17-0676 ID - Lynch2017 ER - TY - STD TI - Langdon S, Hughes A, Taylor MA, Kuczynski EA, Mele DA, Delpuech O, et al. Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity. OncoImmunology. 2018:e1458810. ID - ref24 ER - TY - JOUR AU - Auphan-Anezin, N. AU - Verdeil, G. AU - Schmitt-Verhulst, A. M. PY - 2003 DA - 2003// TI - Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division JO - J Immunol VL - 170 UR - https://doi.org/10.4049/jimmunol.170.5.2442 DO - 10.4049/jimmunol.170.5.2442 ID - Auphan-Anezin2003 ER - TY - JOUR AU - Boyman, O. AU - Sprent, J. PY - 2012 DA - 2012// TI - The role of interleukin-2 during homeostasis and activation of the immune system JO - Nat Rev Immunol VL - 12 UR - https://doi.org/10.1038/nri3156 DO - 10.1038/nri3156 ID - Boyman2012 ER - TY - JOUR AU - Lord, J. D. AU - McIntosh, B. C. AU - Greenberg, P. D. AU - Nelson, B. H. PY - 2000 DA - 2000// TI - The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5 JO - J Immunol VL - 164 UR - https://doi.org/10.4049/jimmunol.164.5.2533 DO - 10.4049/jimmunol.164.5.2533 ID - Lord2000 ER - TY - JOUR AU - Schluns, K. S. AU - Kieper, W. C. AU - Jameson, S. C. AU - Lefrancois, L. PY - 2000 DA - 2000// TI - Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo JO - Nat Immunol VL - 1 UR - https://doi.org/10.1038/80868 DO - 10.1038/80868 ID - Schluns2000 ER - TY - JOUR AU - Sinclair, C. AU - Saini, M. AU - Schim, I. AU - Sakaguchi, S. AU - Seddon, B. PY - 2011 DA - 2011// TI - The long-term survival potential of mature T lymphocytes is programmed during development in the thymus JO - Sci Signal VL - 4 UR - https://doi.org/10.1126/scisignal.2002246 DO - 10.1126/scisignal.2002246 ID - Sinclair2011 ER - TY - JOUR AU - Davis, R. J. AU - Moore, E. C. AU - Clavijo, P. E. AU - Friedman, J. AU - Cash, H. AU - Chen, Z. PY - 2017 DA - 2017// TI - Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid-derived suppressor cells with a selective inhibitor of PI3Kdelta/gamma JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2534 DO - 10.1158/0008-5472.CAN-16-2534 ID - Davis2017 ER - TY - JOUR AU - Lyons, A. B. PY - 2000 DA - 2000// TI - Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution JO - J Immunol Methods VL - 243 UR - https://doi.org/10.1016/S0022-1759(00)00231-3 DO - 10.1016/S0022-1759(00)00231-3 ID - Lyons2000 ER - TY - JOUR AU - Hanzelmann, S. AU - Castelo, R. AU - Guinney, J. PY - 2013 DA - 2013// TI - GSVA: gene set variation analysis for microarray and RNA-seq data JO - BMC Bioinformatics VL - 14 UR - https://doi.org/10.1186/1471-2105-14-7 DO - 10.1186/1471-2105-14-7 ID - Hanzelmann2013 ER - TY - JOUR AU - Rooney, M. S. AU - Shukla, S. A. AU - Wu, C. J. AU - Getz, G. AU - Hacohen, N. PY - 2015 DA - 2015// TI - Molecular and genetic properties of tumors associated with local immune cytolytic activity JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2014.12.033 DO - 10.1016/j.cell.2014.12.033 ID - Rooney2015 ER - TY - JOUR AU - Patro, R. AU - Duggal, G. AU - Love, M. I. AU - Irizarry, R. A. AU - Kingsford, C. PY - 2017 DA - 2017// TI - Salmon provides fast and bias-aware quantification of transcript expression JO - Nat Methods VL - 14 UR - https://doi.org/10.1038/nmeth.4197 DO - 10.1038/nmeth.4197 ID - Patro2017 ER - TY - JOUR AU - Kim, D. AU - Langmead, B. AU - Salzberg, S. L. PY - 2015 DA - 2015// TI - HISAT: a fast spliced aligner with low memory requirements JO - Nat Methods VL - 12 UR - https://doi.org/10.1038/nmeth.3317 DO - 10.1038/nmeth.3317 ID - Kim2015 ER - TY - JOUR AU - Anders, S. AU - Huber, W. PY - 2010 DA - 2010// TI - Differential expression analysis for sequence count data JO - Genome Biol VL - 11 UR - https://doi.org/10.1186/gb-2010-11-10-r106 DO - 10.1186/gb-2010-11-10-r106 ID - Anders2010 ER - TY - JOUR AU - Kramer, A. AU - Green, J. AU - Pollard, J. AU - Tugendreich, S. PY - 2014 DA - 2014// TI - Causal analysis approaches in ingenuity pathway analysis JO - Bioinformatics VL - 30 UR - https://doi.org/10.1093/bioinformatics/btt703 DO - 10.1093/bioinformatics/btt703 ID - Kramer2014 ER - TY - JOUR AU - Newman, A. M. AU - Liu, C. L. AU - Green, M. R. AU - Gentles, A. J. AU - Feng, W. AU - Xu, Y. PY - 2015 DA - 2015// TI - Robust enumeration of cell subsets from tissue expression profiles JO - Nat Methods VL - 12 UR - https://doi.org/10.1038/nmeth.3337 DO - 10.1038/nmeth.3337 ID - Newman2015 ER - TY - JOUR AU - Chen, Z. AU - Huang, A. AU - Sun, J. AU - Jiang, T. AU - Qin, F. X. AU - Wu, A. PY - 2017 DA - 2017// TI - Inference of immune cell composition on the expression profiles of mouse tissue JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep40508 DO - 10.1038/srep40508 ID - Chen2017 ER -